NCT01529853 To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1/PHASE2
NCT01524068 A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations Status WITHDRAWN Phase PHASE2
NCT01504334 Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF) Status UNKNOWN Phase PHASE2
NCT01499745 Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients Status UNKNOWN Phase NA
NCT01462006 Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase NA
NCT01385644 A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT01382368 Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients Status UNKNOWN Phase PHASE4
NCT01366209 Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE3
NCT01362231 A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT01346930 Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis Status WITHDRAWN Phase PHASE2
NCT01321996 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE4
NCT01266135 Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT01265888 Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Status COMPLETED Phase PHASE2
NCT01262001 Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT01254409 A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1
NCT01214187 Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT01203943 A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT01199887 Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT01154998 Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions. Status UNKNOWN Phase N/A